Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin irritation / corrosion

Currently viewing:

Administrative data

Endpoint:
skin corrosion: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
09 December 2015 to 10 December 2015
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2016
Report date:
2016

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 431 (In Vitro Skin Corrosion: Human Skin Model Test)
Deviations:
no
Qualifier:
according to guideline
Guideline:
other: EU Method B.40bis
Deviations:
no
GLP compliance:
yes (incl. QA statement)

Test material

1
Reference substance name:
Fatty acids, tallow, compds. with triethanolamine
EC Number:
263-158-1
EC Name:
Fatty acids, tallow, compds. with triethanolamine
Cas Number:
61790-67-8
IUPAC Name:
Fatty acids, tallow, esters of triethanolamine
Test material form:
liquid
Details on test material:
Appearance: Brown liquid
Storage: At ambient temperature, protected from light

In vitro test system

Test system:
human skin model
Source species:
human
Cell type:
other: EpiDerm™ Reconstructed Human Epidermis
Details on animal used as source of test system:
SOURCE ANIMAL
Model: Three-dimensional reconstructed human epidermis.
- Supplier: MatTek
- Batch number: 23306
- Date recieved: 08 December 2015
Vehicle:
unchanged (no vehicle)
Details on test system:
RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EpiDerm™ Reconstructed Human Epidermis
- Tissue batch number(s): 23306
- Delivery date: 08 December 2015
- Date of initiation of testing: 09 December 2016
Upon receipt of the EpiDerm™ tissues, the sealed 24-well plate was stored in the refrigerator until use.

TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: 37 °C
- Temperature of post-treatment incubation: The plates were refrigerated over night.

REMOVAL OF TEST MATERIAL AND CONTROLS
- Observable damage in the tissue due to washing: None specified

MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 1.0 mg/mL
- Incubation time: 60 minutes
- Spectrophotometer: Anthos 2001 microplate reader.
- Wavelength: 562 nm
After extraction, each tissue was pierced with a pipette fitted with a 1000 µL tip and the extraction solution was forced vigorously up and down to form a homogenous solution. 3 x 200 µL aliquots of the extract were transferred to the appropriate wells of a pre-labelled 96-well plate. 200 µL of isopropanol alone was added to the three wells designated as blanks.
Pre-test procedure – Assessment of direct Test Item reduction of MTT
The MTT assay, a colorimetric method of determining cell viability, is based on reduction of the yellow tetrazolium salt (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) to a blue formazan dye by mitochondrial succinate dehydrogenase in viable cells.
One limitation of the assay is possible interference of the test material with MTT. A test material may directly reduce MTT, thus mimicking dehydrogenase activity of the cellular mitochondria. This property of the test material is only a problem if at the time of the MTT test (after rinsing) there is still a sufficient amount of the test material present on or in the tissues. In this case, the true metabolic MTT reduction and the false direct MTT reduction can be differentiated and quantified.
Test for Direct MTT Reduction:
As specified, a test material may interfere with the MTT endpoint, if it was able to directly reduce MTT and at the same time was present on or in the tissues when the MTT viability test was performed. To identify this possible interference, the test material was checked for the ability to directly reduce MTT according to the procedure below:
50 µL of the test material was added to 1 mL of a freshly prepared 1.0 mg/mL MTT solution. The solution was incubated in the dark at 37 °C, 5 % CO2 in air for 60 minutes. Untreated MTT solution was tested concurrently to act as a control.
If the MTT solution containing the test material turns blue relative to the control, the test material was presumed to have reduced the MTT and the determination of skin corrosion potential would be performed in parallel on viable and freeze-killed tissues for quantitative correction of the results.
The test material was shown to directly reduce MTT in the direct MTT reduction test. There was a possibility that if the test material could not be totally rinsed off the tissues, any residual test material present on or in the tissue may directly reduce MTT and could have given rise to a false negative result. Therefore, the determination of skin corrosion potential was performed in parallel on viable and freeze-killed tissues.
This step was a functional check which employs freeze-killed tissues that possess no metabolic activity but absorb and bind the test material like viable tissues.
In addition to the normal test procedure, the MTT reducing test material was applied to two freeze-killed tissues. In addition, two freeze-killed tissues remained untreated. The untreated freeze-killed control showed a small amount of MTT reduction due to residual reducing enzymes within the killed tissues.

NUMBER OF REPLICATE TISSUES:
Two six-well plates per exposure period.

CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE
- Freeze-killed tissues
- Procedure used to prepare the killed tissues: Freeze-killed tissues were prepared by placing untreated EpiDerm™ tissues in an empty 12-well plate and storing in the freezer (-14 to -30 °C) for a minimum of 24 hours. Before use, each tissue was thawed by placing in 0.9 mL of maintenance medium for approximately 1 hour at room temperature.
- N. of replicates: Two

ASSESSMENT OF COLOUR INTERFERENCE WITH THE MTT ENDPOINT
A test material may interfere with the MTT endpoint if it is coloured. The MTT assay is affected only if the test material is present in the tissues when the MTT viability assay is performed.
50 µL of test material was added to 300 µL of sterile water. The solution was incubated in the dark at 37 °C, 5 % CO2 in air for 60 minutes. A visual assessment of the colour was then made.

PRE-INCUBATION
The assay medium was pre-warmed before use. 0.9 mL of this assay medium was pipetted into the appropriate wells of two pre-labelled 6-well plates for both the 3-minute and 60-minute exposure periods. EpiDerm™ tissues were transferred into the 6-well plates containing the assay medium. The 6-well plates containing the EpiDerm™ samples were pre-incubated (37 °C, 5 % CO2) for approximately 1 hour before dosing.

APPLICATION OF TEST MATERIAL AND RINSING
Before pre-incubation was complete, a 24-well plate was prepared for use as a “holding plate” for both the 3-minute and 60-minute exposure periods. This plate was used to maintain the viability of the tissue inserts between rinsing following chemical exposure and MTT loading. Another 24-well plate was prepared for the MTT loading. 300 µL of either pre-warmed assay medium (holding plate) or MTT medium (MTT loading plate) was dispensed into each well. The two plates were placed into the incubator until required.
After pre-incubation of the EpiDerm™ tissues, the medium was aspirated and replaced with 0.9 mL of fresh assay medium. The 6-well plate for the 3-minute exposure period was returned to the incubator, while the other was being dosed for the 60-minute exposure. For the 60-minute exposure period, 50 µL of sterile distilled water (negative control) was added to the first two tissues. The tissues were dosed at regular intervals to allow for the time taken to rinse each tissue following exposure and to ensure that each tissue gets an equal exposure time. 50 µL of the test material and 50 µL of 8.0 N potassium hydroxide (positive control) were also applied to the corresponding tissues in turn. The plate was returned to the incubator (37 °C, 5 % CO2) for the 60-minute exposure period.
When dosing for the 60-minute exposure period was complete, the same procedure was repeated for the 3-minute exposure period. Because the exposure time was so short, the tissues were dosed at regular intervals to ensure that each tissue received an equal exposure time and to allow for the time taken to rinse each tissue following exposure. Rinsing was achieved by filling and emptying each tissue under a constant soft stream of DPBS to gently remove any residual test material. Excess DPBS was removed by blotting the bottom of the tissue insert with tissue paper. Each tissue was placed into the prepared holding plate until all tissues were rinsed. They were then blotted and transferred to the 24-well plate prepared for MTT loading. The plate was incubated (37 °C, 5 % CO2) for 3 hours. Once the 60-Minute exposure period was complete, the same rinsing and MTT loading procedure was repeated.
After the 3-hour MTT incubation was complete, the inserts were blotted and transferred to labelled 24-well plates for MTT extraction. 2 mL of MTT extractant (isopropanol) was used to completely immerse each insert and the plate was covered with plate sealer to prevent Isopropanol evaporation. The plates were placed into a refrigerator overnight, to allow extraction to proceed

PREDICTION MODEL / DECISION CRITERIA
- The test substance is considered to be corrosive to skin if the viability after 3 minutes exposure is less than 50 %, or if the viability after 3 minutes exposure is greater than or equal to 50 % and the viability after 1 hour exposure is less than 15 %.
Control samples:
yes, concurrent negative control
yes, concurrent positive control
Amount/concentration applied:
TEST MATERIAL
- Amount applied: 50 µL

NEGATIVE CONTROL
- Amount applied: 50 µL. The negative control item was used as described.

POSITIVE CONTROL
- Amount applied: 50 µL. The positive control item was used as described.
Duration of treatment / exposure:
3 minute and 60 minute exposure periods.
Duration of post-treatment incubation (if applicable):
3 hours
Number of replicates:
Duplicate tissues were treated with the test material, negative and positive control.

Results and discussion

In vitro

Resultsopen allclose all
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
3 minute exposure period
Value:
103.4
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
60 mintute exposure period
Value:
102.4
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Other effects / acceptance of results:
- OTHER EFFECTS:
- Direct-MTT reduction:
An assessment found the test material was able to directly reduce MTT. Therefore, an additional procedure using freeze-killed tissues was performed during the determination of skin irritation potential. However, the results obtained showed a negligible degree of interference (0.9 % relative to the negative control after 3 minutes exposure and 0.0 % relative to the negative control after 60 minutes exposure) due to direct reduction of MTT occurred. It was therefore considered unnecessary to use the results of the freeze-killed tissues for quantitative correction of results.

3 minutes exposure:
Mean of test material treated killed tissues (tkt) = 0.149 OD562
Mean of untreated killed tissues (ukt) = 0.132 OD562
The direct reduction by the test material relative to the negative control value:
(0.149 (tkt) – 0.132 (ukt)) / 1.884 (mean of negative control) = 0.9 %

60 minutes exposure:
Mean of test material treated killed tissues (tkt) = 0.114 OD562
Mean of untreated killed tissues (ukt) = 0.150 OD562
The direct reduction by the test material relative to the negative control value:
(0.144 (tkt) – 0.150 (ukt)) / 1.886 (mean of negative control) = 0.0 %

- Colour interference with MTT:
The solution containing the test material did not become coloured. This was taken to indicate the test material did not have the potential to cause colour interference.

QUALITY CRITERIA
The mean OD562 for the negative control treated tissues was 1.884 for the 3 Minute exposure period and 1.886 for the 60 Minute exposure period. The negative control acceptance criteria were therefore satisfied.

The relative mean tissue viability for the positive control treated tissues was 5.1 % relative to the negative control following the 60 Minute exposure period. The positive control acceptance criterion was therefore satisfied.

In the range 20-100 % viability the Coefficient of Variation between the two tissue replicates of each treatment group did not exceed 30 %. The acceptance criterion was therefore satisfied.

Any other information on results incl. tables

Table 1: Mean OD562Values and Viabilities for the Negative Control Item, Positive Control Item and Test Material

Tissue

Exposure

Period

Mean OD562

of

individual

tissues

Mean OD562

of duplicate

tissues

Standard Deviation

Coefficient

of Variation

(%)

Relative

Mean

Viability

(%)

Negative

Control

3 Minutes

2.066

1.884

0.257

13.7

100*

1.702

60 Minutes

1.786

1.886

0.141

7.5

1.985

Positive

Control

3 Minutes

0.109

0.107

0.003

N/A

5.2

0.105

60 Minutes

0.091

0.096

0.006

N/A

5.1

0.100

Test Material

3 Minutes

2.025

1.949

0.108

5.6

103.4

1.872

60 Minutes

1.879

1.931

0.074

3.8

102.4

1.983

OD = Optical density

* = The mean % viability of the negative control tissue is set at 100 %.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
Under the conditions of this study, the test material was determined to be non-corrosive to the skin
Executive summary:

A study was performed in vitro to assess the corrosive potential of the test material in accordance with the standardised guidelines OECD 431 and EU Method B.40bis under GLP conditions.

Duplicate tissues were treated with the test material for exposure periods of 3 and 60 minutes. The test employed the use of the EpiDerm™ Human Skin Model. Negative and positive control groups were treated for each exposure period. The test material was found to directly reduce MTT and therefore additional non-viable tissues were incorporated into the testing for correction purposes. At the end of the exposure period the test material was rinsed from each tissue before each tissue was taken for MTT-loading. After MTT loading each tissue was placed in 2 mL Isopropanol for MTT extraction.

At the end of the formazan extraction period each well was mixed thoroughly and triplicate 200 µL samples were transferred to the appropriate wells of a pre-labeled 96-well plate. The optical density (OD) was measured at 562 nm (OD562).

The mean OD562 for the negative control treated tissues was set at 100 for both the 3 minute and 60 minute exposure period. The relative percentage tissue viability for the positive control treated tissues was 5.2 % for a 3 minute exposure and 5.1 for the 60 minute exposure period. 

The relative mean viability of the test material treated tissues was 103.4 for the 3 minute exposure period and 102.4 for the 60 minute exposure period.

Under the conditions of this study, the test material was determined to be non-corrosive to the skin.